Neos Therapeutics announces proposed offering of common stock
Neos Therapeutics announced it has commenced an underwritten public offering of $30 million in shares of its common stock. In addition, Neos has granted the underwriter a 30-day option to purchase up to an additional $4.5 million in shares of common stock sold in connection with the offering. June 26, 2017